Trial Operation And Production Of Astragalus Membranaceus in Shaanxi, China

On January 6, 2020, the National Health Commission and the State Administration of market supervision jointly issued the notice on the pilot work of substance management of 9 items such as dangshen, which is both food and traditional Chinese medicine according to tradition. These nine substances include Codonopsis pilosula, Cistanche deserticola, Dendrobium candidum, American ginseng, astragalus, Ganoderma lucidum, Cornus Officinalis, Gastrodia elata, and Eucommia ulmoides leaves.

At present, Astragalus membranaceus is a pilot operation and production in Shaanxi, China. The drug and food homologous substances produced in the pilot must be physically processed according to the traditional production process or eating habits, excluding the chemical extraction of their components.